United States· US:0078-1224_8683b06e-4901-4526-89ad-23a8fe2d1331
LOCAMETZ
A medicinal product containing gozetotide, registered in United States by Novartis Pharmaceuticals Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GOZETOTIDE
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1100781224611 VIAL, MULTI-DOSE in 1 CARTON (0078-1224-61) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE
- ndc110078-1224-61
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gozetotide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaILLUCCIXTelix Innovations, Herstal
- FinlandIlluccixTelix Innovations
- BelgiumIlluccix 25 µgTelix Innovations
- SwedenIlluccix 25 mikrogram Beredningssats för radioaktivt läkemedelTelix Innovations
- NetherlandsIlluccix 25 microgram kit voor radiofarmaceutisch preparaatTelix Innovations S.A.
- IrelandIlluccix 25 micrograms kit for radiopharmaceutical preparationTelix Innovations
- GermanyIlluccixTelix Innovations
- FranceILLUCCIX 25 microgrammes, trousse pour préparation radiopharmaceutiqueTELIX INNOVATIONS (BELGIQUE)
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Illuccix, Isoprotrace
- Belgium · Illuccix, Isoprotrace
- Cyprus · Illuccix, Isoprotrace
- Czechia · Illuccix, Isoprotrace
- Germany · Illuccix, Isoprotrace
- Denmark · Illuccix, Isoprotrace
- Spain · Illuccix, Isoprotrace
- Finland · Illuccix, Isoprotrace
- France · Illuccix, Isoprotrace
- United Kingdom (Northern Ireland) · Illuccix, Isoprotrace
- Greece · Illuccix, Isoprotrace
- Ireland · Illuccix
- Iceland · Locametz
- Italy · Illuccix, Viewprost
- Liechtenstein · Locametz
- Luxembourg · Illuccix, Isoprotrace
- Malta · Illuccix, Isoprotrace
- Netherlands · Illuccix, Isoprotrace
- Norway · Illuccix, Isoprotrace
- Poland · Psmatrace
- Portugal · Illuccix, Isoprotrace
- Sweden · Illuccix, Isoprotrace
- Slovakia · Illuccix, Isoprotrace
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e248e5f8-5dc8-4355-937a-5f028dc19b2e GET /v1/drugs/e248e5f8-5dc8-4355-937a-5f028dc19b2e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "25",
"substance": "GOZETOTIDE",
"productndc": "0078-1224",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "ug/1",
"application_number": "NDA215841",
"marketing_category": "NDA"
}See everything about gozetotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.